Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

García‐Olmo, Damián; Gilaberte, Inmaculada; Binek, Matthias; J.L. D ́Hoore, André; Lindner, Dirk; Selvaggi, Francesco; Spinelli, Antonino; Panés, Julián

doi:10.1097/dcr.0000000000002325

Public

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

Published in Diseases of the Colon & Rectum • Dec 10, 2021

Authors:

Damián García‐Olmo

Inmaculada Gilaberte

Matthias Binek

Abstract

BACKGROUND: Darvadstrocel is an expanded allogeneic adipose-derived mesenchymal stem cell therapy for the treatment of complex perianal fistulas in patients with Crohn's disease. Safety and efficacy outcomes from the clinical trial known as "Adipose derived mesenchymal stem cells for induction of re...

Subject

Medicine

Crohn's disease

Adverse effect

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!